Schedule 13G ownership disclosure

MAINZ BIOMED N V

Common Stock · CUSIP: N5436L101

Event date: 2025-10-17

Filing-level shares
685,000.00
Percent of class
10.7%
  • Donahue Kevin Michael

    Shares: 685,000.00 · Class: 10.7%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0002105585-26-000006
Form type
SCHEDULE 13G/A
Filer
Donahue Kevin Michael
CIK
CIK 2105585
Filed
Jan 20, 2026
Reporting period
Oct 17, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub